Navigation Links
Bioethicist explores hypochondria in new book from OUP
Date:7/31/2012

New York City, August 1, 2012-- The "hypochondriac" is a complicated figure, often treated with scorn and derision, resented for making excessive demands on attention and health care resources. Lacking credibility but needing to be taken seriously, the hypochondriac is most doctors' least favorite patient. Yet people who suffer from hypochondria endure the anxiety of suspecting they are seriously ill, or are about to be, and having their suspicions and their suffering dismissed as baseless.

Catherine Belling, author of the new book, A Condition of Doubt: The Meanings of Hypochondria, seeks to change the way Americans think about hypochondria, and to use hypochondria as a lens to sharpen our thinking about health care. Belling argues that contemporary hypochondria should be understood less as mental illness in particular patients than as a rational if maladaptive condition emerging from gaps between doctors' and patients' expectations of contemporary Western medicine.

In addition, Belling claims that over the last half-century, patients have become more open to uncertainty and ambiguity but medicine has not, and claims that hypochondria--as a shared cultural condition--can be addressed by rethinking both patients' expectations of medical omniscience and physicians' need to meet such expectations. Belling would urge for a reconceptualizing of hypochondria and, more broadly, reconceptualizing medicine's orientation toward the unknown.


'/>"/>
Contact: John Hercel, OUP Marketing
john.hercel@oup.com
212-726-6291
Oxford University Press
Source:Eurekalert

Page: 1

Related medicine news :

1. Study Explores Distractions Role in Pain Relief
2. EB-5 Expert Brian Su Explores Chinese Inbound Investments in Southern California
3. San Francisco EB-5 Conference explores inbound Chinese investments
4. Acne No More Review Explores Product Aimed at Curing Acne Naturally
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... ... As part of the nationwide Days of Remembrance effort led by the United ... persecution, Center for Medicine after the Holocaust (CMATH) announced that it will ... and Poland next week. , The Fourth Biennial CMATH Champions Trip to Germany and ...
(Date:4/24/2017)... ... , ... Today, Bright Pink , a national non-profit organization focusing on the prevention and ... , Bright Pink is proud to announce Katie Thiede as their new Chief Executive Officer. ... as Chairman of the Board and launched a national search to find a visionary ...
(Date:4/24/2017)... ... April 24, 2017 , ... Veteran Theresa James awoke to the ... life forever. , In “Healing Tears,” James depicts every parent’s worst nightmare, when her ... I began journaling conversations and situations throughout my divorce,” James said. “After the death ...
(Date:4/24/2017)... ... 2017 , ... The world-class designers of Happy Gadget Alert ... lifesaving device for the everyday use of parents worldwide. It is a lightweight, ... a child’s vital signs, and detect unusual symptoms or physical patterns. This innovative ...
(Date:4/24/2017)... ... April 24, 2017 , ... symplrTM, a leading provider of ... that Kyle Allain has joined the company as Vice President and General Manager ... provider, payor and managed care solutions. , A seasoned executive with more ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 19, 2017 Global Prostate Cancer Therapeutics ... the prostate cancer therapeutics market analyzes the current ... prevalence of prostate cancer, launch of promising emerging ... of new drugs & therapeutic biological products, and ... to lesser side effects are some of the ...
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, Inc. ... clinical-stage biopharmaceutical company developing new treatments for cancer ... closing of its previously announced underwritten public offering ... a public offering price of $2.00 per share, ... offering expenses payable by Sorrento.  The net proceeds ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-naïve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
Breaking Medicine Technology: